ahlam1399
08-04-2015, 08:13 PM
Pfizer wins EU approval for $15 billion Hospira buy
BRUSSELS (Reuters) - U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some ***** to allay competition concerns.
http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2.img (http://da.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/ach.img (http://adchoice.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/ach.htm)http://pi.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48b32b29/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=iyetzO7UHVw:9YtLPyAX5FI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=iyetzO7UHVw:9YtLPyAX5FI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=iyetzO7UHVw:9YtLPyAX5FI:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=iyetzO7UHVw:9YtLPyAX5FI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=iyetzO7UHVw:9YtLPyAX5FI:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/iyetzO7UHVw
BRUSSELS (Reuters) - U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some ***** to allay competition concerns.
http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2.img (http://da.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/ach.img (http://adchoice.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/ach.htm)http://pi.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234566668031/u/49/f/654207/c/35217/s/48b32b29/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48b32b29/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=iyetzO7UHVw:9YtLPyAX5FI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=iyetzO7UHVw:9YtLPyAX5FI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=iyetzO7UHVw:9YtLPyAX5FI:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=iyetzO7UHVw:9YtLPyAX5FI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=iyetzO7UHVw:9YtLPyAX5FI:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/iyetzO7UHVw